46 Biggest Movers From Yesterday

Gainers

• ATA Inc. ATAI shares jumped 81.6 percent to close at $3.85 on Wednesday after the company's stock continued momentum from an increase of over 100% in yesterday's trading session following news of the company entering into preliminary agreements to acquire a leading Chinese service provider.
• Marathon Patent Group, Inc. MARA rose 41.39 percent to close at $3.86.
• Inpixon INPX shares surged 47.87 percent to close at $1.18 on Wednesday following news of a deal to buy Locality Systems.
• Global Brass and Copper Holdings Inc BRSS gained 25.18 percent to close at $43.30 after the company announced a definitive merger agreement with Wieland-Werke AG at $44 per share in cash.
• Titan Medical Inc. TMDI rose 20.64 percent to close at $2.6300.
• Fulgent Genetics, Inc. FLGT climbed 20.14 percent to close at $6.80.
• Simulations Plus, Inc. SLP gained 13.28 percent to close at $22.61 after reporting stronger-than-expected earnings for its second quarter.
• Boxlight Corporation BOXL climbed 13.15 percent to close at $3.2700.
• American Renal Associates Holdings, Inc. ARA rose 12.25 percent to close at $6.69.
• Guardant Health Inc GH gained 11.8 percent to close at $73.99 after Bank of America upgraded the stock from Neutral to Buy and raised the price target from $81 to $84.
• AzurRx BioPharma, Inc. AZRX rose 11.59 percent to close at $2.60.
• Coda Octopus Group, Inc. CODA climbed 10.71 percent to close at $12.40.
• Catabasis Pharmaceuticals, Inc. CATB rose 10.68 percent to close at $9.64.
• Riot Blockchain, Inc. RIOT rose 10.38 percent to close at $4.89.
• Adient plc ADNT climbed 10.2 percent to close at $18.15.
• Syndax Pharmaceuticals, Inc. SNDX rose 10.14 percent to close at $6.30.
• Safe-T Group Ltd SFET gained 9.54 percent to close at $2.87 after the company announced plans to acquire a business proxy network solution provider, NetNut, for $9.7 million in cash and stock.
• IZEA Worldwide Inc IZEA gained 8.91 percent to close at $1.10 after reporting first-quarter bookings of $7.8 million, up 18 percent year over year.
• First Solar, Inc. FSLR gained 8.27 percent to close at $60.77 after Goldman Sachs added the stock to its Conviction Buy list and raised the price target from $64 to $75.
• Tempur Sealy International, Inc. TPX climbed 7.03 percent to close at $63.66 after multiple analysts said the departure of the Mattress Firm CEO would be beneficial for the company.
• Tata Motors Limited TTM gained 6.78 percent to close at $15.76 after the company reported that its March global wholesales increased by 32 percent compared to the previous month, despite this being a 5 percent decrease year-over-year.
• MediciNova, Inc. MNOV gained 6.61 percent to close at $10.49.
• Zayo Group Holdings, Inc. ZAYO gained 5.7 percent to close at $31.13 following a media report the company will be acquired by Digital Colony Partners.
• Amyris, Inc. AMRS shares gained 5.63 percent to close at $3.75. Amyris received notification of deficiency from the Nasdaq related to delayed annual report on Form 10-K.
• Sorrento Therapeutics, Inc. SRNE gained 4.16 percent to close at $4.26 after the company announced positive topline results in a discovery trial of a potential non-dopaminergic approach to controlling Parkinson's motor symptoms with Resiniferatoxin Intrathecal Administration.
• Levi Strauss & Co. LEVI gained 4 percent to close at $22.75 after reporting first-quarter earnings of 37 cents per share, up from $(0.05) year over year. Sales came in at $1.434 billion, up from $1.344 billion year over year. The company sees 2019 adjusted EBIT margin flat to slightly up, with sales growth in the mid-single-digit range.

Losers

• Helius Medical Technologies Inc HSDT shares tumbled 66.18 percent to close at $2.10 after the FDA declined the company's request for its De Novo classification and 510(k) clearance of the PoNS device.
• Outlook Therapeutics, Inc. OTLK shares dipped 45.08 percent to close at $1.7300. Outlook Therapeutics priced its 10.34 million share offering at $2.75 per share.
• Wave Life Sciences Ltd. WVE fell 18.78 percent to close at $33.91 after the company announced it would delay the data readout timeline on its Huntington's Disease trial.
• SemiLEDs Corporation LEDS dropped 17.25 percent to close at $4.4600.
• Foresight Energy LP FELP dipped 15.5 percent to close at $1.6900.
• PAR Technology Corporation PAR fell 13.7 percent to close at $21.55 after the company announced a proposed offering of $60 million of senior convertible notes.
• Sibanye Gold Limited SBGL fell 13.6 percent to close at $3.9400 after the company announced it intends to raise $120 million to cover its debt from share sales.
• Fuel Tech, Inc. FTEK dropped 13.21 percent to close at $2.43.
• PhaseBio Pharmaceuticals, Inc. PHAS fell 11.84 percent to close at $12.88 following news of a 3 million share common stock offering.
• Flexion Therapeutics, Inc. FLXN dropped 11.43 percent to close at $11.00.
• Netshoes (Cayman) Limited NETS declined 11.29 percent to close at $2.2000.
• Lyft, Inc. LYFT shares tumbled 10.85 percent to close at $60.12 after competitor Uber said it plans to sell $10 billion of stock in a May IPO.
• Calix Inc CALX shares fell 10.51 percent to close at $7.07 after the company cut its Q1 guidance figures.
• Powerbridge Technologies Co., Ltd. PBTS declined 10.5 percent to close at $5.71.
• AVROBIO, Inc. AVRO tumbled 10.48 percent to close at $22.09.
• PolarityTE, Inc. PTE dropped 10.18 percent to close at $9.44. PolarityTE priced its common stock offering for approximately $27.5 million total.
• Avinger Inc AVGR shares fell 9.29 percent to close at $0.8300 on Wednesday after the company received FDA clearance for its Pantheris SV device.
• SPI Energy Co., Ltd. SPI dipped 9.25 percent to close at $3.6300.
• Homology Medicines, Inc. FIXX dropped 6.19 percent to close at $22.11. Homology Medicines priced its 5.55 million share public offering of common stock at $22.50 per share.
• WD-40 Company WDFC fell 5.07 percent to close at $163.60. WD-40 reported upbeat earnings for its second quarter, while sales missed estimates. The company reaffirmed 2019 earnings and sales guidance.